Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Airbus Shares Gain Momentum on Strong Operational Performance

Andreas Sommer by Andreas Sommer
January 20, 2026
in Analysis, Defense & Aerospace, Earnings, European Markets, Industrial
0
Airbus Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The equity of European aerospace giant Airbus is demonstrating strength, buoyed by a solid operational foundation and growing confidence from the financial community. The company’s latest delivery figures have surpassed expectations, and its ambitious production roadmap is receiving a vote of confidence from leading analysts.

Analyst Sentiment Turns Bullish

A wave of optimism from market researchers is currently supporting Airbus’s stock. Several prominent institutions have recently revised their price targets upward, reflecting growing conviction in the company’s trajectory.

  • Goldman Sachs increased its target to €250 from €240.
  • Deutsche Bank adjusted its forecast upward to €250 from €222 on January 13.
  • UBS raised its target to €240 from €230, reiterating its “Buy” recommendation ahead of the quarterly results scheduled for February 19.
  • Barclays maintains a “Buy” rating with a steady price target of €220.

The consensus price target among analysts now stands at approximately €240. With shares trading around €218 as of January 16, this implies a potential upside of about 10%. These adjustments signal a belief that Airbus is effectively navigating supply chain complexities and is on track to execute its production increases.

Delivery Performance Exceeds Guidance

Airbus’s commercial aircraft business closed the last year on a high note, exceeding its own revised delivery target. The company handed over 793 commercial aircraft in 2025, beating its adjusted goal of 790 units. This represents a 4% increase compared to the 766 deliveries made in the prior year.

Should investors sell immediately? Or is it worth buying Airbus?

The company had initially targeted 820 deliveries for the year but was compelled to revise this figure downward due to a quality issue identified in fuselage sections for its A320 family aircraft. Despite this setback, the final tally demonstrates resilient operational execution.

Record Backlog Underpins Long-Term Outlook

Future visibility remains exceptionally strong, supported by an order book that reached a record 8,754 aircraft by the end of 2025. This total includes 1,124 wide-body aircraft. Throughout the year, Airbus secured 1,000 gross orders from 57 customers. After accounting for cancellations, the net order intake stood at 889, highlighting sustained demand for its modern, fuel-efficient aircraft portfolio.

Production Ramp-Up Proceeds Amid Persistent Challenges

Airbus continues to advance its strategic plan to increase the production rate of its A320 family to 75 aircraft per month by 2027. According to Christian Scherer, the former CEO of Airbus Commercial Aircraft, this expansion plan remained on track as of the latest assessment.

While broader supply chain pressures have eased, the company anticipates that uncertainties related to engine deliveries from Pratt & Whitney will persist into 2026. This remains a critical watchpoint for ensuring on-time deliveries, though Scherer noted it was not the primary limiting factor at the close of 2025. The company’s ability to manage this specific bottleneck is seen as key to maintaining its production momentum.

Ad

Airbus Stock: Buy or Sell?! New Airbus Analysis from February 7 delivers the answer:

The latest Airbus figures speak for themselves: Urgent action needed for Airbus investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Airbus: Buy or sell? Read more here...

Tags: Airbus
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Next Post
Palantir Stock

Palantir Shares Approach a Critical Juncture

Omv Stock

OMV Shares Navigate Headwinds from Romanian Impairment

DeFi Technologies Stock

DeFi Technologies Stock: A High-Stakes Dilemma for Investors

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com